Top Markets
Coin of the day
Regenicin, Inc. Regenicin, Inc.

Regenicin, Inc.

RGIN
주식 순위 #41589
Regenicin, Inc. is dedicated to the development and commercialization of... Regenicin, Inc. is dedicated to the development and commercialization of advanced tissue-engineered skin replacement technologies. Its product line features NovaDerm, a sophisticated multi-layered living and cultured skin substitute engineered for treating burn injuries, alongside TempaDerm, which addresses more localized wound areas like ulcers. These innovative solutions aim to rejuvenate the characteristics of healthy human skin, finding application in burn therapy, chronic wound management, and various plastic surgery procedures. Incorporated in 2007 and based in Little Falls, New Jersey, the company was previously known as Windstar, Inc., adopting the Regenicin, Inc. name in July 2010.
주가
$0.0001
마지막 동기화: 2026-08-11
시가총액
$15.35K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Regenicin, Inc. (RGIN)

카테고리

Regenicin, Inc. (RGIN)의 EPS
2026 기준 EPS TTM: 0
Regenicin, Inc.의 최신 재무 보고서와 주가에 따르면, 현재 EPS (TTM)는 0입니다. 2026년 말에는 회사의 EPS가 0였으며, 이는 2026년의 EPS 0와 동일입니다.
Regenicin, Inc.의 EPS 기록 (2026 ~ 2026)
매년 말의 EPS
연도 EPS 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 EPS